Christopher Yea
Corporate Officer/Principal at KALVISTA PHARMACEUTICALS, INC.
Net worth: 839 976 $ as of 29/04/2024
Network origin in Christopher Yea first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 24 | |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Vantia Ltd.
 Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Christopher Yea via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Founder Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PULMONX CORPORATION | Medical Specialties | Sales & Marketing Sales & Marketing | |
TRIA Beauty, Inc.
 TRIA Beauty, Inc. Medical SpecialtiesHealth Technology TRIA Beauty, Inc. provides light based therapeutic beauty devices. It offers TRIA Laser Hair Removal System for laser removal of hair and TRIA Skin Perfecting Blue Light for mild to moderate inflammatory acne with a proprietary cleanser and serum for overall complexion improvement. The company was founded in 2003 by Tobin C. Island, Robert E. Grove, Jonathon T. Pearson and Mark V. Weckwerth and is headquartered in Dublin, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Neomend, Inc.
 Neomend, Inc. BiotechnologyHealth Technology Neomend, Inc. develops surgical wound healing products. It offers adhesion prevention products for hospitals and medical facilities. The company was founded in 1999 and is headquartered in Irvine, CA. | Biotechnology | Director/Board Member President | |
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital Management LP (RA Capital) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Peter Kolchinsky in 2004. RA Capital provides discretionary investment advisory services to Healthcare Funds and the Nexus Funds which are open only to certain financially sophisticated and high net-worth individuals and entities. | Investment Managers | Founder Portfolio Manager-Equities | |
| Boston College | College/University | Undergraduate Degree Undergraduate Degree | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| CONCERT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder Chief Operating Officer | |
Corixa Corp.
 Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Director/Board Member Sales & Marketing | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Investor Relations Contact | |
Young Men's Christian Association of Greater Boston, Inc.
 Young Men's Christian Association of Greater Boston, Inc. Miscellaneous Commercial ServicesCommercial Services The YMCA of Greater Boston, Inc. provides social services. The firm offers youth development, healthy living and social responsibility services. It conducts pre-K, youth, teen, adult., family programs and provides early education care services. The company was founded in 1851 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| MINERVA SURGICAL, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital Management LP (Private Equity) (RA Capital) is a private equity & venture capital subsidiary of RA Capital Management LP founded by Peter Kolchinsky in 2004. The firm is headquartered in Boston, MA. | Investment Managers | Private Equity Investor Private Equity Investor | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member Investor Relations Contact | |
Seqirus Vaccines Ltd.
 Seqirus Vaccines Ltd. BiotechnologyHealth Technology Seqirus Vaccines Ltd. manufactures vaccines. The company is headquartered in Maidenhead, the United Kingdom. | Biotechnology | President Corporate Officer/Principal | |
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of Manchester | College/University | Doctorate Degree Doctorate Degree | |
| VISTERRA INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| New York University | College/University | Undergraduate Degree Undergraduate Degree | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Masters Business Admin | |
| Chelsea College | College/University | Undergraduate Degree | |
Faraday Pharmaceuticals, Inc. (Washington)
 Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Faraday Pharmaceuticals, Inc. develops small molecule drugs for the treatment of central nervous system disorders and cardiovascular diseases. The company was founded in 2001 and is headquartered in Seattle, WA. | Drugstore Chains | Corporate Officer/Principal | |
| Imperial College London | College/University | Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Glaxo, Inc. | General Counsel | ||
The Organisation for Professionals in Regulatory Affairs Ltd
 The Organisation for Professionals in Regulatory Affairs Ltd Miscellaneous Commercial ServicesCommercial Services The Organisation for Professionals in Regulatory Affairs Ltd is a professional membership organization that provides training courses, conferences, and networking opportunities for individuals engaged in regulatory affairs for human and veterinary medicines and medical devices worldwide. The non-profit company is based in London, UK. The organization offers resources for improving professional competence and industry standing, including newsletters, medical device resources, and a glossary of regulatory affairs terms. | Miscellaneous Commercial Services | General Counsel | |
CHAIN Biotechnology Ltd.
 CHAIN Biotechnology Ltd. BiotechnologyHealth Technology CHAIN Biotechnology Ltd. develops new clostridium-based microbial technology for high value healthcare products. It produces novel 2nd generation live bio therapeutic products (LBPs) for chronic gut-related diseases, such as Inflammatory Bowel Disease (IBD). The company was founded by Edward Green and Basil Omar in 2014 and is headquartered in Marlow, the United Kingdom. | Biotechnology | Director/Board Member | |
Macomics Ltd.
 Macomics Ltd. Miscellaneous Commercial ServicesCommercial Services Macomics Ltd. engages in research and experimental development on biotechnology. The company was founded by Jeffrey William Pollard and Luca Cassetta on November 6, 2018 and is headquartered in Edinburgh, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
ChapelPharma Ltd.
 ChapelPharma Ltd. Medical/Nursing ServicesHealth Services Part of Averion International Corp., ChapelPharma Ltd. specializes in regulatory and clinical consultancy services. The company is based in Hungerford, UK. The British company was founded by Rachel M. Morten. ChapelPharma was acquired by Hesperion AG on November 25, 2004. | Medical/Nursing Services | Founder | |
Averion International Corp.
 Averion International Corp. Miscellaneous Commercial ServicesCommercial Services Averion International Corp. provides clinical research services. It serves for pharmaceutical, biotechnology and medical device industries. The company mainly focuses on oncology, nephrology, dermatology and medical devices. The company was founded on April 22, 2002 and is headquartered in Southborough, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| EXACT THERAPEUTICS | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Rodaris Pharmaceuticals | Director/Board Member | ||
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| University of Michigan | College/University | Undergraduate Degree | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Corporate Officer/Principal | |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer |
Statistics
International
| United States | 34 |
| United Kingdom | 13 |
| Canada | 3 |
| Switzerland | 2 |
| Israel | 2 |
Sectoral
| Health Technology | 29 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Finance | 4 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 187 |
| Corporate Officer/Principal | 60 |
| Independent Dir/Board Member | 47 |
| Founder | 26 |
| Chairman | 22 |
Most connected contacts
| Insiders | |
|---|---|
| Martin Edwards | 38 |
| Joshua Resnick | 36 |
| Arnold Lewis Oronsky | 35 |
| Richard H. Aldrich | 31 |
| Albert Cha | 30 |
| Brian Pereira | 23 |
| Robert Tansley | 18 |
| Raj Shah | 16 |
| David Renzi | 14 |
| Don Soland | 14 |
| Ben Palleiko | 13 |
| Edward Unkart | 13 |
| Patrick Treanor | 10 |
| Nancy Stuart | 10 |
| Hilary McElwaine-Johnn | 8 |
- Stock Market
- Insiders
- Christopher Yea
- Company connections
